A procedure based on spectral analysis of whole body movements was developed to quantify chlordecone-induced tremor in rats. Male, Fischer-344 rats were given single or repeated ip doses of chlordecone, and whole body tremor was measured at 2.5-Hz intervals from 2.5 to 20 Hz. The most prevalent frequency and associated magnitude were recorded. Spectral analysis of the tremor produced by single doses of chlordecone could be differentiated from the spectral analysis of movement produced by various doses of harmine (5 to 20 mg/kg, ip) and apomorphine (0.5 to 2 mg/kg ip). The administration of 10 to 100 mg/kg chlordecone produced measurable tremor at 1, 5, 12, and 24 hr postdosing. The peak effect of chlordecone on tremor occurred at 12 hr postdosing. The most prevalent frequency of chlordecone-induced tremor was approximately 12 Hz following 50 to 100 mg/kg, 5 to 24 hr postdosing. Tremor was also quantified in rats receiving 5 to 10 mg/kg chlordecone daily for 10 consecutive days. Twenty-four hr after the last dose of chlordecone, spectral analysis indicated a peak frequency that was approximately the same as that obtained following acute administration of higher doses (≅12 Hz). Subsequent experiments with trihexyphenidyl and pizotifen suggested that the tremor produced by chlordecone might have a cholinergic and serotonergic component.